Witryna4 sie 2015 · This study is a randomized, double-blind, placebo-controlled clinical trial of a new formulation of GEN-003 for treatment of HSV-2 genital infection. Eligible subjects will enter a baseline period to collect anogenital swabs for 28 consecutive days prior to randomization. Each subject will receive up to 3 doses at 21 day intervals then … Witryna29 lis 2024 · Potential vaccines for herpes simplex virus (HSV) may prevent or treat symptoms of an HSV infection. HSV vaccines must pass through several steps before …
Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection ...
WitrynaHerpes simplex virus (HSV) is an alpha herpes virus, with two subtypes: HSV-1 and HSV-2. HSV is one of the most prevalent sexually transmitted infections. It is the cause of severe neonatal infections and a leading cause of infectious blindness in the Western world. As of 2016, 13.2% of the global population ages 15–49 were existing with HSV … Witryna1 kwi 2003 · Phase 3. Detailed Description: This study is a double-blind, randomized, controlled Phase III trial to assess the prophylactic efficacy and safety of gD-Alum/MPL vaccine in the prevention of genital herpes disease in young women who are herpes simplex virus (HSV)-1 and -2 seronegative. The primary efficacy objective is to … children\u0027s songs about peace
Therapeutic Vaccine for Genital Herpes Simplex Virus-2 …
Witryna15 mar 2024 · Background: Genital herpes simplex virus type 2 (HSV-2) infection causes recurrent lesions and frequent viral shedding. GEN-003 is a candidate therapeutic vaccine containing HSV-2 gD2∆TMR and ICP4.2, and Matrix-M2 adjuvant. Methods: Persons with genital herpes were randomized into 3 dose cohorts to receive 3 … Witryna21 gru 2024 · BioNTech doses first patient in herpes vaccine candidate clinical trial The vaccine candidate is meant to prevent HSV-2, the herpes simplex virus that causes … WitrynaPosdoc in Tropical Medicine in Oswaldo Cruz Foundation. International Researcher in Bernhard-Nocht-Institut für Tropenmedizin (PhD Sandwich ). Qualified Professional with 9+ years clinical sciences experience in Molecular Biology, Viral Herpes Studies, Zika Virus,Cell Culture, Pharmaceutical drug trials and Vaccine program. gowhimsey